Do we already have the powerful drugs we need to treat COVID-19? Maybe. In order to find out, we will also need a clearer perspective and fuller understanding of the drug repurposing process.
As the SARS-CoV-2 virus, which causes COVID-19, traverses the globe, already responsible for more than 18 million infections and more than 700,000 reported deaths worldwide, the public has developed an acute, albeit tragic, understanding that infectious disease cannot be tamed on-demand. Many are understandably focused on the development of a vaccine, and very promising advances in antibody therapeutics are being reported. But we must also recognize that, prior to that breakthrough, medicine is not completely powerless in the battle against this disease.